Form 4: RXO Director Michelle Nettles Receives New RSU Grant

RXO, Inc. Director Michelle Nettles was granted 14,517 Restricted Stock Units, which will vest in 2027 and are subject to a deferral election.

Summary

• Michelle Nettles, a Director of RXO, Inc., was granted 14,517 Restricted Stock Units (RSUs) on January 2, 2026.
• Each RSU represents a contingent right to receive either one share of Common Stock or a cash payment equal to the fair market value of one share of Common Stock upon settlement.
• These newly granted RSUs are scheduled to vest in full on January 2, 2027, contingent upon Ms. Nettles' continued service as a director of the Issuer.
• Shares of Common Stock for these RSUs will be delivered to Ms. Nettles as per the terms of a deferral election.
• Following this reported transaction, Ms. Nettles beneficially owns 22,262 derivative securities (RSUs).
• The total beneficial ownership includes 7,745 underlying shares of Common Stock from previously vested RSUs on January 2, 2026, which also became subject to a deferral election.

Sentiment

Score: 6

Explanation: The filing reports a routine equity grant to a director, which is a neutral to slightly positive event as it aligns director interests with shareholders. There are no significant positive or negative surprises that would materially impact the company's outlook.

Positives

• The grant of 14,517 Restricted Stock Units aligns the director's long-term financial interests with those of the shareholders.
• The vesting condition, requiring continued service, reinforces the director's commitment to the company's future performance.
• The deferral election provides flexibility for the director in managing their equity compensation and potential tax implications.

Negatives

• There is no immediate liquidity from the RSU grant as vesting is deferred until January 2, 2027.
• The ultimate value realized from the RSUs is contingent on the future market price of RXO, Inc. Common Stock.

Risks

• The value of the Restricted Stock Units is subject to the market price fluctuations of RXO Common Stock.
• Vesting of the RSUs is contingent on the director's continued service; forfeiture could occur if service ceases before the January 2, 2027 vesting date.

Future Outlook

The 14,517 Restricted Stock Units granted to Michelle Nettles are scheduled to vest in full on January 2, 2027, provided her continued service as a director of RXO, Inc. Shares of Common Stock will be delivered according to a deferral election for both the newly granted RSUs and the previously vested 7,745 RSUs.

Industry Context

This filing is a routine insider transaction report (Form 4) detailing equity compensation for a director. It reflects standard corporate governance practices where directors receive equity awards to align their interests with shareholders, and does not provide broader industry context or trends.

Stakeholder Impact

• Shareholders: The grant of RSUs aligns the director's long-term interests with shareholders, potentially encouraging decisions that enhance shareholder value. Minor potential for future dilution upon share issuance.
• Employees: No direct impact on general employees.
• Customers/Suppliers/Creditors: No direct impact.

Next Steps

• The 14,517 RSUs are expected to vest on January 2, 2027, subject to Michelle Nettles' continued service.
• Shares of Common Stock will be delivered to the Reporting Person as per the terms of the deferral election for both the newly granted RSUs and the previously vested 7,745 RSUs.

Key Dates

Recommendation

This Form 4 filing details a routine equity compensation grant to an existing director and does not contain information that would fundamentally alter the investment thesis for RXO, Inc. It is a standard disclosure of insider activity, aligning director incentives with long-term shareholder value, but it does not provide new insights into the company's operational or financial performance to warrant a change in investment recommendation.

Keywords

RXO, Michelle Nettles, Restricted Stock Units, RSU, Director Compensation, Equity Grant, SEC Form 4, Insider Transaction, Stock Vesting, Deferral Election